SC halts Glenmark from selling copies of Merck’s diabetes drugs

The Supreme Court of India has barred Glenmark from selling copies of Merck’s diabetes drugs - Januvia and Janumet

justice

(Photo Courtesy: www.corupriesthood.com)

The SC has, however, allowed Glenmark to sell its existing stocks of these two drugs.

The judgment brings a great relief to Merck after two years, when in 2013 it sued its opponent for infringing its patent on the compound sitagliptin, which is present in both the drugs.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X